RAFAEL HOLDINGS, INC. Income (Loss) Attributable to Noncontrolling Interest, before Tax
RAFAEL HOLDINGS, INC. (RFL) reported Income (Loss) Attributable to Noncontrolling Interest, before Tax of -$53.00 thousand for the 3-month period ending 2023-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossAttributableToNoncontrollingInterest · last filed 2023-06-13
- RAFAEL HOLDINGS, INC. income (loss) attributable to noncontrolling interest, before tax for the quarter ending 2023-04-30 was -$53.00K.
- RAFAEL HOLDINGS, INC. income (loss) attributable to noncontrolling interest, before tax for the quarter ending 2023-01-31 was -$159.00K.
- RAFAEL HOLDINGS, INC. income (loss) attributable to noncontrolling interest, before tax for the quarter ending 2022-04-30 was -$19.00K.
- RAFAEL HOLDINGS, INC. income (loss) attributable to noncontrolling interest, before tax for the quarter ending 2022-01-31 was -$244.00K.
| Period end | Income (Loss) Attributable to Noncontrolling Interest, before Tax 3 month | Income (Loss) Attributable to Noncontrolling Interest, before Tax 6 month | Income (Loss) Attributable to Noncontrolling Interest, before Tax 9 month |
|---|---|---|---|
| 2023-04-30 | -$53.00K 10-Q · filed 2023-06-13 | -$212.00K derived: sum of 2 quarters · filed 2023-06-13 | -$311.00K 10-Q · filed 2023-06-13 |
| 2023-01-31 | -$159.00K 10-Q · filed 2023-03-14 | -$258.00K 10-Q · filed 2023-03-14 | |
| 2022-04-30 | -$19.00K 10-Q · filed 2023-06-13 | -$263.00K derived: sum of 2 quarters · filed 2023-06-13 | -$17.65M 10-Q · filed 2023-06-13 |
| 2022-01-31 | -$244.00K 10-Q · filed 2023-03-14 | -$17.63M 10-Q · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |